Traduction de «article stipulates the regulation » (Néerlandais → Français) :

This article stipulates The regulation states that production, quality and pharmacovigilance standards need to be determined for these products;
This article stipulates The regulation states that production, quality and pharmacovigilance standards need to be determined for these products;

Que l'article 767, § 2, alinéa 1er, du Code judiciaire stipule que si l'avis est donné par écrit, le Ministère public en donne lecture et le dépose à l'audience dans le délai fixé par le juge conformément à l'article 766, alinéa, 1er, aux jour et heure fixés lors de la clôture des débats et indiqués sur la feuille d'audience; que l'avis est déposé toutefois dans le même délai au greffe sans qu'il en soit fait lecture lorsque le premier juge en a décidé ainsi ou dans le cas visé à l'article 755; que l'article 767, § 2, alinéa 2, précise que lorsque l'avis ne peut être rendu dans le délai, la cause du retard est indiquée sur la feuille d'audience;
Que l’article 767, § 2, alinéa 1er, du Code judiciaire stipule que si l’avis est donné par écrit, le Ministère public en donne lecture et le dépose à l’audience dans le délai fixé par le juge conformément à l’article 766, alinéa, 1er, aux jour et heure fixés lors de la clôture des débats et indiqués sur la feuille d’audience; que l’avis est déposé toutefois dans le même délai au greffe sans qu’il en soit fait lecture lorsque le premier juge en a décidé ainsi ou dans le cas visé à l’article 755; que l’article 767, § 2, alinéa 2, précise que lorsque l’avis ne peut être rendu dans le délai, la cause du retard est indiquée sur la feuille d’audience;

A European regulation that has entered into force on 1 July 2004 stipulates that, in order to inform the consumer of possible health risks, the labelling of beverages that contain caffeine in a proportion in excess of 150 mg/l should contain the mention “high caffeine content” followed by the caffeine content expressed in mg/100 ml in the same field of vision as the name under which the product is sold (Directive 2002/67/EC).
Enfin, une réglementation européenne, entrée en vigueur au 1er juillet 2004, stipule que l’étiquetage de boissons contenant plus de 150 mg de caféine par litre doit comporter la mention « teneur élevée en caféine » et la mention de sa quantité (en mg/100 ml) dans le même champ de vision du produit afin d’avertir le consommateur des risques possibles pour la santé (Directive 2002/67/CE).

Thus the sale of non-prescription drugs over the Internet is regulated in it, “Good dispensing pharmaceutical practices” are stipulated and rules relating to the organisation of the night-duty service are established.
Thus the sale of non-prescription drugs over the Internet is regulated in it, “Good dispensing pharmaceutical practices” are stipulated and rules relating to the organisation of the night-duty service are established.

Herbal medicinal products In line with the provisions of the royal decree of 14 December 2006, three procedures are used for the issue of the MA or registration for herbal medicinal products: the full procedure, the “Well Established Use” procedure and a third specific procedure for traditional herbal medicines as stipulated in article 43 of the royal decree.
Herbal medicinal products In line with the provisions of the royal decree of 14 December 2006, three procedures are used for the issue of the MA or registration for herbal medicinal products: the full procedure, the “Well Established Use” procedure and a third specific procedure for traditional herbal medicines as stipulated in article 43 of the royal decree.

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines
1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines

Bij vragen omtrent de Better Regulation on Variations neemt u best ook de Q&A van het CMDh en de lijst van gepubliceerde Article 5 Recommendations bij de hand.
Pour des questions relatives à la Better Regulation on Variations, il est préférable que vous ayez également à portée de main le Q&A du CMDh et la liste des Article 5 Recommendations publiées.

EFSA - European Food Safety Authority. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to conjugated linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.
linoleic acid (CLA) isomers and contribution to the maintenance or achievement of a normal body weight (ID 686, 726, 1516, 1518, 2892, 3165), increase in lean body mass (ID 498, 731), increase in insulin sensitivity (ID 1517), protection of DNA, proteins and lipids from oxidative damage (ID 564, 1937), and contribution to immune defences by stimulation of production of protective antibodies in response to vaccination (ID 687, 1519) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.